← Leaderboards
Joshua D Nosanchuk
Johns Hopkins University
$4,457,092
Attributed
$6,504,402
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,504,402 · 7
By mechanism
R01$4,526,480 · 3
R21$999,652 · 2
R41$600,000 · 1
K08$378,270 · 1
Top collaborators
- Arturo Casadevall3 shared
- Ruth E. Stark3 shared
- Andrew R Draganski2 shared
- Marcio Lourenco Rodrigues2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Susanna M Thon$1,151,443
- Arturo Casadevall$47,974,076
- Ruth E. Stark$6,150,743
- Craig A Townsend$23,597,395
- John D Tovar$2,396,609
Others in their field
Top investigators on “Cryptococcus Neoformans”
- Arturo Casadevall · Johns Hopkins University$33,951,910
- Joseph Heitman · Duke University$33,924,189
- Hiten D Madhani · University Of California, San Francisco$24,815,163
- Maurizio Del Poeta · Northport Va Medical Center$22,300,489
- Tamara L Doering · Washington University$20,134,929
- Stuart M Levitz · Duke University$16,533,146
Research focus
Cryptococcus NeoformansPathogenesisFungusAffectMycosesVirulenceInsightPathogenInfectionCellsYeastsOrganismPreventCessation Of LifeImmunityLeadMacrophageAcquired Immunodeficiency SyndromeAntifungal AgentsMelaninsGrowthProductionLifeAntigens
Grant awards (20)
The biology of Cryptococcus neoformans melanization$785,315
R01 · FY2025 · AI
An extracellular vesicle component as a candidate to control cryptococcosis.$130,212
R01 · FY2025 · AI
The biology of Cryptococcus neoformans melanization$809,603
R01 · FY2024 · AI
An extracellular vesicle component as a candidate to control cryptococcosis.$115,880
R01 · FY2024 · AI
The biology of Cryptococcus neoformans melanization$841,478
R01 · FY2023 · AI
Development and optimization of a nitric oxide releasing microparticle-basedtopical treatment for onychomycosis$300,000
R41 · FY2023 · AI
Development and optimization of a nitric oxide releasing microparticle-basedtopical treatment for onychomycosis$300,000
R41 · FY2022 · AI
Candida auris extracellular vesicles subvert host immune responses$252,000
R21 · FY2022 · AI · contact PI
Candida auris extracellular vesicles subvert host immune responses$210,000
R21 · FY2021 · AI · contact PI
Antibody differentially alters Histoplasma extracellular vesicles$242,911
R21 · FY2017 · AI · contact PI
Antibody differentially alters Histoplasma extracellular vesicles$294,741
R21 · FY2016 · AI · contact PI
Antibody Protection in Histoplamosis$347,418
R01 · FY2009 · AI · contact PI
Antibody Protection in Histoplamosis$52,735
R01 · FY2009 · AI · contact PI
Antibody Protection in Histoplamosis$347,418
R01 · FY2008 · AI · contact PI
Antibody Protection in Histoplamosis$354,146
R01 · FY2007 · AI · contact PI
Antibody Protection in Histoplamosis$363,442
R01 · FY2006 · AI · contact PI
Antibody Protection in Histoplamosis$378,833
R01 · FY2005 · AI
MELANOGENESIS IN CRYPTOCOCCUS NEOFORMANS$126,090
K08 · FY2002 · AI
MELANOGENESIS IN CRYPTOCOCCUS NEOFORMANS$126,090
K08 · FY2001 · AI
MELANOGENESIS IN CRYPTOCOCCUS NEOFORMANS$126,090
K08 · FY2000 · AI